The time-course of plasma angiotensinogen (Ao), elastase-c~Fprotease inhibitor complex (ELc~IPI), antithrombin III (AT III) and C-reactive protein (CRP) have been investigated of six patients suffering from adult respiratory distress syndrome (ARDS).
Angiotensinogen (Ao) is the only known precursor of the vasoactive peptide hormone angiotensin. This plasma glycoprotein is synthesized and secreted by the liver. Various hormones are known to be involved in its synthesis and secretion, including angiotensin II (Khayyal et al., 1973) , oestrogens and glucocorticoids (Crane et al., 1971) , and thyroid hormones (Dzau and Herrmann, 1982) . Subsequent to publication of the cDNA sequence of Ao by Ohkubo and coworkers (1983) , a sequence relationship to the serpin (serine protease inhibitors) family, antithrombin III (ATIII), ovalbumin and expecially to ~Za-protease inhibitor (oqPI) was detected by Doolittle (1983) . This was supported by the finding of Tanaka et al. (1984) , showing a common structural organization of the Ao and (zlPI genes. C~lPI interacts with lysosomal enzymes, including kallikrein, various cathepsins and especially elastase to form the elastase-~-protease inhibitor complex (ELazPI). A III is the most important inhibitor of the clotting system (Travis and Salvesen, 1983) . ATIII and (ZlPI are acute-phase reactants in various animals (Koj and Regoeczi, 1978; Kushner, 1982) , whereas in humans A III is not (Martinez-Brot6ns et al., 1987) . C-reactive protein (CRP) is a further acute-phase reactant, which does not belong to the serpin family. The physiological role of CRP is not yet comletely understood (McCarty, 1982) . Recent data have shown that CRP-peptides are potent immunomodulators (Robey et al., 1987) . Within hours following acute inflammation, the synthesis of these proteins is increased in the liver and their plasma concentration is elevated by as much as 2000-fold (Koj and Gordon, 1983; Morley and Kushner, 1982) . It has recently been shown that administration of lipopolysaccharides (LPS) to rats results in a marked increase in oqPI and Ao mRNA in the liver and an increase in plasma Ao levels (Hilgenfeldt, 1988) . These findings indicate that Ao is a member of the acute-phase reactant class in rats. To verify its role in inflammatory diseases in men, the plasma levels of Ao have been compared over a 4 week period with those of EL~IPI, AT III and CRP in patients suffering from septic ARDS (Modig, 1986) .
Materials and methods

Patients
Plasma samples from six patients (3 male, 3 female) with a mean age of 33 (18.5, SD) y and a mean weight of 67.7 kg, admitted to the Intensive Care Unit, Klinikum Gro6hadern, University of Munich Mean (SD) 0.88 (0.24) nmol Ao/ml. Plasma angiotensinogen in pregnant women (right group), n = 12, 6.2 (1.3) nmol Ao/ml. The solid line is the calculated correlation between the assays and the dotted line shows the theoretical 1 : 1 correlation were investigated. Clinical data are given in Table 1 . Only patients kept in the Intensive Care Unit for more than 10 days were eligible for the study. These critically ill patients all suffered from bacterial sepsis and the adult respiratory distress syndrome (ARDS) (Modig, 1986) . All patients received antibiotics, low dose heparin, diazepam, morphine and pancuronium bromide. In addition, furosemide was administered if urine flow was reduced. Epinephrine and dopamine were administered to five of the six patients (except P 10) to maintain blood pressure and kidney function.
Criteria for exclusion. Patients were excluded in cases of negative blood culture or no focus of severe infection. Patients with liver failure evidenced by history and laboratory tests, with neoplastic disease, with any chronic illness, or who received glucocorticoids or oral contraceptives were also excluded.
Preparation of plasma. Up to four blood samples per day were obtained from indwelling venous catheters. Blood was collected in 5 ml plastic tubes containing 0.5 ml trisodium citrate 0.13 M. Plasma was prepared by centrifugation of citrated blood at 1000 g for 10 min at room temperature and frozen at -70°C in plastic tubes.
Assay ofangiotensinogen. Ao was completely purified from plasma obtained from the Department of Gynaecology, University of Heidelberg by a five step procedure. Purity was verified by amino acid analysis, end group sequence analysis and complete liberation of N-terminal angiotensin I by renin. The protein had a specific activity of 21.1gg ANGI.mg -~ protein. Asuming a molecular weight of 60,000 Da for human angiotensinogen, the preparation has a purity of 98% (Kienapfel, 1987) . Antibodies against human Ao were raised in rabbits by the method of Vaitukaitis et al. (1971) . Plasma Ao concentrations were determined by a direct radioimmunoassay (RIA) performed according to the method described for rat Ao . Antiserum was used at 1:25000. The sensitivity of the assay was i fmol Ao. In addition, an indirect assay following enzymatic cleavage of AngI with an excess of renin (Hilgenfeldt and Hackenthal, 1979) , was also used. AngI was measured by RIA (Menard and Catt, 1972) . Ang I antiserum was raised in rabbits using glutaraldehyde-linked angiotensin I. The serum was analyzed for cross-reactivity with AngII. The antibody titre for Ang I and Ang II differed by 5.104.
Assay of elastase-~l-proteinase inhibitor complex (EloqPl).
ELohPI complex was measured using a commercial, solid phase, enzymelinked, sandwich immunoassay (E. Merck AG, Darmstadt, FRG), as described by Jochum et al. (1983) . The range was from 20 to 150 gg alPI-complex per litre.
U. Hilgenfeldt et al.: Plasma angiotensinogen in septic ARDS
Assay of plasma antithrombin (A TIII). Plasma AT III concentration
was determined with a commercial thrombin inhibition assay (S-2238, Deutsche Kabi-Vitrum, Munich) using p-nitroaniline as the cromogenic product.
Assay of C-reactive protein (CRP).
The concentration of C-reactive protein was measured by radial immunodiffusion using a commercial test system (Behring Werke AG, Marburg, FRG). The coefficient of correlation was calculated by comparing different parameters of every plasma sample of each patient using the computer program Microsoft Chart.
Results
Control plasma Ao levels
The values obtained by the direct and indirect assays for Ao were compared by measuring the angiotensinogen content in plasma from 25 healthy volunteers. The plasma Ao levels were 0.876 (0.278) nmol Ao.m1-1 and 0.874 (0.237) nmol Ang I-ml-1 (mean (SD). This indicates that in healthy man the plasma Ao fluctuates within a narrow range. In addition plasma from 10 healthy pregnant women, with the pregnancy dependent elevation of Ao was also tested. The mean plasma Ao was 6.19 (1.25) nmol Ao.m1-1 and 6.07 (1.6) nmol AngI.ml-L As shown in Fig. 1 , the correlation coefficient between the direct and indirect assays for Ao in both groups was close to 1.
Patients
Ao, ELcqPI, AT III and CRP were analyzed in 209 different plasma samples from 6 patients. As shown in Fig tient. The amount of Ao in all patients was increased at some time during the period of observation. In addition, the values obtained by the direct and indirect measurement show marked differences. In contrast to the control data given in Fig. 1 , the two assay systems did not show a 1:1 ratio in plasma from these patients, although the values were still correlated (Table 2) . Within a certain period, the values obtained with the direct assay were significantly higher in P9, P 17, P45 and P53. This indicates increased formation of AngI, leading to an increased plasma concentration of des-AngI-Ao. Stimulation of the components of the renin-angiotensin system, e. g. Ao, renin, Ang I and Ang II, in some of these patients has recently been reported . The Ao values obtained by the direct assay were compared with the levels of ELoqPI, AT III and CRP. Plasma Ao and ELalPI in all six patients are shown in Fig. 3 . A positive correlation of Ao and ELCZlPI was not observed in most patients. Only in P 10 was there fluctuation of the ELalPI values around the Ao values, although they were not positively correlated; in P53 r = 0.734 was found within five days after admission.
The plasma levels of Ao and AT III are shown in Fig. 4 . A positive correlation of Ao and AT III was evident in plasma from three patients during the entire observation period, with r between 0.69 and 0.71. The other three patients (P 10, P 48 and P 53) show a good correlation within a limited period (Table 2, data in parentheses), cqPI and AT III are members of the same gene family and so are related to angiotensinogen. However, the acute phase protein CRP does not belong to this group. The plasma levels of Ao and CRP are shown in Fig. 5 . It is interesting to note that in P10, P48 and P53 the Ao and CRP values were positively correlated at the beginning of the illness. In the time interval in which plasma Ao and CRP were positively correlated, however, Ao and ATIII showed a negative or no correlation (see Table 1 ). A correlation between CRP and EL~IPI was less common. In addition, there was no or almost a negative correlation between CRP and AT III in plasma from all the patients.
Discussion
The mean plasma Ao level in healthy volunteers was 0.9 (0.3) ~tM. An increase in plasma Ao is observed in pregnancy, in women taking oral contraceptives, and in hypertension (Gordon, 1983) . The possibility that Ao may behave as an acute-phase protein was first raised by Bing (1972) , although he did not find an increase in plasma Ao levels following turpentine injection in the rat. The idea that Ao may be an acute-phase reactant was revived after the finding that Ao was genetically closely related to ~IPI (Doolittle, 1983 and Tanaka et al., 1984) . The idea was supported by the finding of as much as a five-fold increase in Ao mRNA in liver ) and a threefold increase in plasma Ao levels (Hilgenfeldt, 1988) following lipopolysaccharide administration to rats. Although these data are consistent with the hypothesis that Ao is an acute-phase reactant in humans, caution is needed in inferring that data from one species can be applied to another; for example, oqPI is not an acute-phase reactant in mice (Baumann et al., 1986) , and CRP demonstrates striking species variations in response to tissue injury (Pepys et al., 1979) . Nielsen and Knudsen (1987) recently reported a 70% increase in plasma Ao levels in patients with acute inflammatory disease, indicating that Ao may be an acute-phase reactant in man. Since the regulation of plasma Ao levels is complex, an increased level on its own cannot be accepted as proof of this hypothesis. The acute-phase response occurs in the period immediately following injury and infection. Therefore, the present study was designed to follow the time course of change in Ao levels in patients with bacterial sepsis. The changes were compared with those in known acute-phase reactants.
Increased plasma levels of Ao were found during the first 3 to 5 days of observation in five of the six patients. The correlation between Ao and the other acute-phase proteins in our studywas based on the direct RIA for Ao. This assay recognizes the total Ao concentration and ignores Ao catabolism by plasma renin. In addition, both proteins, intact Ao and des-AngI-Ao, have an almost identical plasma half life in vivo (Hilgenfeldt, 1988) and should be eliminated to a similar extent.
The individual course of the disease in each patient makes it difficult to find a common principle. It is impossible at present to model such complex curves of different plasma parameters, so it is only possible to compare different parameters from each plasma sample and to fit them in a linear correlation. A relationship between Ao and o~lrI was seen in only one patient during five days after admission (P53; r=0.73). However, the assay for ~IPI only measured the ELczlPI-complex and not the total amount of o~aPI. Therefore, a correlation between Ao and O~lPI would only have been detected if the amount of the ELalPI-complex and of free a~PI were linked. A far stronger relationship was found between Ao and ATIII, with a significant correlation during the entire observation period in three patients (P9, P 17, P45). In those patients no correlation of Ao and CRP was found. The other three patients, P10, P48, P53, displayed a good correlation between Ao and CRP during the initial part of the study (r = 0.78, 0.79, 0.78) . During this period both parameters were negatively correlated with ATIII (Ao-ATIII: r--0.48, -0.68, and -0.64; CRP-ATIII: r = -0.40, -0.62, -0.71). In the subsequent period Ao and ATIII displayed a good correlation (r= 0.73, 0.87, 0.72) without being related to CRR The good correlation of the plasma levels of Ao and CRP during the first several days of hospitalization suggests that Ao is an acute-phase reactant in man. That this correlation was not found in all six patients was mainly due to the fact that data from the initial acute-phase could only be obtained from one patient (P48). On the other hand, plasma Ao and ATIII levels showed a far closer relationship, although AT III is not an acute-phase protein in man (Martinez-Brotdns et al., 1987) . However this correlation is observed during a time period when Ao and CRP are not correlated. This indicates that in the latter period the acute-phase has already been terminated. A correlation in the plasma levels of genetically related proteins like Ao, ~IPI and ATIII, indicates not only a similar U. Hilgenfeldt et al.: Plasma angiotensinogen in septic ARDS synthetic response to stimuli, but in addition it points to similar rates of catabolism and elimination, despite their molecular and functional differences. There is evidence of increased Ao catabolism in acute inflammation, since there is a decrease in the in vivo half-life of one form of Ao in rats following LPS stimulation. Decreased renal elimination, which might be caused by decreased renal blood flow, has also been discussed (Hilgenfeldt, 1988) .
At present a common stimulus for acute-phase proteins cannot be defined. Very recently it has been shown that the synthesis of various acute-phase proteins is mediated by cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor-c~ (TNF-c0, by a direct action on hepatocytes (Ramadori et al., 1988) . However while the secretion of a2-macroglobulin is markedly accelerated by IL-6, the secretion of cysteine proteinase inhibitor and c~lPI is unaffected (Andus et al., 1988) . On the other hand, a macrophage derived factor is able to stimulate the synthesis and secretion both of AT III and cqPI (Hoffmann et al., 1986) . The biosynthesis of the most prominent acute-phase protein CRP by the liver is presumably mediated by interleukin-1 (Kaplan, 1982; Syin et al., 1986 and Goldberger et al., 1987) . Very recently it has been shown that the acute-phase response of Ao is mediated by interleukin-6 in rat hepatoma cells (Itoh et al., 1989) , but this requires the presence of glucocorticoids, suggesting that the latter are essential for the stimulatory effect.
The role of angiotensinogen in inflammation cannot yet be defined. It appeared from a previous study that the renin-angiotensin system did not play a role in the maintenance of blood pressure in such patients. However, angiotensin may be important in the immune response during inflammation (Fernandez-Castello et al., 1987) .
In conclusion, up to a five-fold increase in plasma Ao levels has been found in patients suffering from septic ARDS. The positive correlation between Ao and CRP during the first days after admittance to the intensive care unit indicates that Ao is an acute-phase reactant in man. There was also a good correlation between plasma Ao and ATIII levels during the later stage of disease, suggesting similarities in the synthesis and elimination kinetics of these proteins. Further studies are required to define the functional role of Ao in inflammatory diseases.
